Jupiter Topco LLC purchased a new position in Envista Holdings Corporation (NYSE:NVST – Free Report) during the 2nd quarter, Holdings Channel.com reports. The firm purchased 480,349 shares of the company’s stock, valued at approximately $12,658,000.
Several other institutional investors have also bought and sold shares of NVST. Royal Bank of Canada grew its stake in shares of Envista by 26.6% in the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock worth $401,000 after buying an additional 4,885 shares in the last quarter. Millennium Management LLC raised its position in shares of Envista by 218.6% during the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after buying an additional 263,442 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after acquiring an additional 177,630 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Envista by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after acquiring an additional 76,246 shares during the last quarter. Finally, Prudential Financial Inc. grew its position in Envista by 22.1% in the second quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock worth $367,000 after acquiring an additional 3,395 shares in the last quarter.
Envista Stock Performance
Shares of NYSE:NVST opened at $27.15 on Friday. The firm has a market cap of $4.36 billion, a PE ratio of 46.81, a price-to-earnings-growth ratio of 1.29 and a beta of 0.86. The firm’s 50 day simple moving average is $27.12 and its 200-day simple moving average is $26.38. Envista Holdings Corporation has a one year low of $18.77 and a one year high of $30.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43.
Insider Transactions at Envista
In other Envista news, SVP Mischa Reis sold 8,000 shares of the stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the transaction, the senior vice president directly owned 27,321 shares in the company, valued at $751,327.50. This represents a 22.65% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is currently owned by insiders.
Analyst Ratings Changes
NVST has been the topic of several analyst reports. Morgan Stanley set a $23.00 price objective on Envista in a research note on Thursday, August 6th. BMO Capital Markets began coverage on Envista in a report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 target price for the company. Barclays cut their target price on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research report on Thursday, June 11th. JPMorgan Chase & Co. raised their price target on Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Finally, Evercore reaffirmed an “outperform” rating and set a $33.00 price objective on shares of Envista in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $29.31.
Check Out Our Latest Stock Report on NVST
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Further Reading
- Five stocks we like better than Envista
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
